Responses
Regular and young investigator award abstracts
Clinical trials completed
260 T cell infiltrating repertoire diversity is associated with enhanced survival following neoadjuvant therapy in patients with resectable pancreatic cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.